These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31169437)

  • 21. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection.
    Shen SL; Fu SJ; Chen B; Kuang M; Li SQ; Hua YP; Liang LJ; Guo P; Hao Y; Peng BG
    Ann Surg Oncol; 2014 Nov; 21(12):3802-9. PubMed ID: 24849520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Fushiya N; Koike K; Nishino H; Tajiri H
    Br J Cancer; 2012 Sep; 107(6):988-93. PubMed ID: 22878374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel combined prognostic nutritional index and aspartate aminotransferase-to-platelet ratio index-based score can predict the survival of patients with hepatocellular carcinoma who undergo hepatic resection.
    Yugawa K; Maeda T; Nagata S; Sakai A; Edagawa M; Omine T; Kometani T; Yamaguchi S; Konishi K; Hashimoto K
    Surg Today; 2022 Jul; 52(7):1096-1108. PubMed ID: 35066743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization.
    Liu Y; Shi M; Chen S; Wan W; Shen L; Shen B; Qi H; Cao F; Wu Y; Huang T; Chen G; Mo J; Ye D; Zhang Y; Feng Z; Fan W
    J Cancer Res Ther; 2021 Jul; 17(3):740-748. PubMed ID: 34269308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
    Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
    Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
    Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
    Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy.
    Lin ZX; Ruan DY; Jia CC; Wang TT; Cheng JT; Huang HQ; Wu XY
    Clin Transl Oncol; 2020 Mar; 22(3):370-380. PubMed ID: 31201606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the impact of prognostic factors for hepatocellular carcinoma over time.
    Toyoda H; Kumada T; Tada T; Yama T; Mizuno K; Sone Y; Maeda A; Kaneoka Y; Akita T; Tanaka J
    Cancer Sci; 2017 Dec; 108(12):2438-2444. PubMed ID: 28945309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of serum gamma-glutamyltransferase levels in patients with hepatocellular carcinoma.
    Sun L; Wang R; Gao FY; Li YX; Geng MF; Chen JL; Ye XQ; Li XS; Yang X; Wan G; Yang ZY; Wang XB
    Neoplasma; 2017; 64(3):444-452. PubMed ID: 28253724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
    Chu MO; Shen CH; Chang TS; Xu HW; Yen CW; Lu SN; Hung CH
    Sci Rep; 2018 Nov; 8(1):16611. PubMed ID: 30413724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative platelet-albumin-bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection: A retrospective study.
    Luo HM; Zhao SZ; Li C; Chen LP
    Medicine (Baltimore); 2018 Mar; 97(12):e0226. PubMed ID: 29561452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Predictive Value of Platelet to Lymphocyte Ratio and Prognostic Nutritional Index on Prognosis of Hepatocellular Carcinoma after Liver Resection].
    Qin L; Yang XL; Li C; Luo YL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 49(4):645-648. PubMed ID: 30378321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic role of inflammatory biomarkers in HIV-infected patients with a first diagnosis of hepatocellular carcinoma: A single-center study.
    Quiros-Roldan E; Properzi M; Amadasi S; Raffetti E; Ferraresi A; Biasi L; Focà E; Castelli F
    J Med Virol; 2019 Feb; 91(2):241-248. PubMed ID: 30216474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation.
    Zhang Q; Jiao X
    Comput Math Methods Med; 2021; 2021():9809990. PubMed ID: 34845414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The optimal cut-off value of the preoperative prognostic nutritional index for the survival differs according to the TNM stage in hepatocellular carcinoma.
    Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Surg Today; 2017 Aug; 47(8):986-993. PubMed ID: 28315008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy.
    Lai L; Su T; Liang Z; Lu Y; Hou E; Lian Z; Gao H; Zhu X
    J Cancer; 2020; 11(22):6642-6652. PubMed ID: 33046985
    [No Abstract]   [Full Text] [Related]  

  • 38. A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients.
    Mao M; Wang X; Sheng H; Liu Y; Zhang L; Dai S; Chi PD
    BMC Cancer; 2018 Nov; 18(1):1178. PubMed ID: 30486825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients.
    Liang X; Liangliang X; Peng W; Tao Y; Jinfu Z; Ming Z; Mingqing X
    Sci Rep; 2021 Jul; 11(1):14624. PubMed ID: 34272447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.
    Lin YJ; Lee MH; Yang HI; Jen CL; You SL; Wang LY; Lu SN; Liu J; Chen CJ
    PLoS One; 2013; 8(4):e61448. PubMed ID: 23613855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.